Abstracts of the XXVth Congress of the European Association of Veterinary Anatomists (EAVA), Oslo, 28-31 July 2004: Distribution and Activity of Fatty Acid Amide Hydralase (FAAH) in the Gastrointestinal Neurons of Mouse

• Published in: Anatomia, histologia, embryologia histologia, embryologia, 2005-12, Vol.34 (s1), p.13-13
• Main Authors: Costagliola, A, Russo, D, Izzo, A A, Urbani, P, Marzo, V, Cecio, A
• Format: Article
• Language: English
• ISSN: 0340-2096; 1439-0264
• DOI: 10.1111/j.1439-0264.2005.00669_28.x

The endocannabinoid anandamide may regulate intestinal motility through activation of CB1 receptors. Anandamide is then inactivated by fatty acid amide hydrolase (FAAH), a membrane bound enzyme. Under pathological conditions, inactivation of such enzymatic activity may lead to inhibition of the intestinal motility. Here, preliminary reports on the distribution of Fatty Acid Amide Hydrolase (FAAH) immunoreactivity in the mouse gastrointestinal neurons, and the pharmacological effects of N-arachidonoylserotonin (AA-5HT), a selective inhibitor of FAAH, are reported. FAAH was revealed by an indirect immunofluorescence. Laminar preparations containing the myenteric or the submucous plexus adhered, were peeled off after the whole gut wall had been stretched out and fixed in 4% paraformaldehyde. They were subsequently incubated with a polyclonal anti-serum directed against a region near the N-terminus of the human FAAH and revealed by a FITC-conjugated goat anti-rabbit secondary anti-serum. FAAH-immunoreactive neurons were observed within the myenteric ganglia throughout the GIT. The positive nerve cells varied in size and density of immunoreactivity. Stomach and large intestine showed the highest neuronal density. AA-5HT significantly reduced both gastric emptying and gastrointestinal tract transit. Such inhibitory effect was reduced by the C1 receptor antagonist SR141716A. Both morphological and pharmacological results suggest that FAAH may play a critical role in controlling gut anandamide levels.